Lu Yue
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 5
- Circular RNAs in diseases 4
- Cancer-related gene regulation 3
- Oncology 12
- Peptidase Inhibition and Analysis 4
- Cancer-related Molecular Pathways 3
- Co-authors
- Ruyong Yao (13 shared papers)Liwei Wang (2 shared papers)Weiyi Huang (2 shared papers)Yuanjue Sun (2 shared papers)Xiaohan Zhou (2 shared papers)Wensheng Qiu (7 shared papers)Yasai Yao (6 shared papers)Fang Zhou (6 shared papers)
- Journals
- Oncology Reports (3 papers)Medical Oncology (2 papers)Clinical and investigative medicine (2 papers)Molecular Therapy (1 paper)BMC Medical Genomics (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Lu Yue
34 papers receiving 857 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 234
- Biological Psychiatry 29
- Molecular Biology 627
- Oncology 227
- Hematology 45
Countries citing papers authored by Lu Yue
This map shows the geographic impact of Lu Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Yue more than expected).
Fields of papers citing papers by Lu Yue
This network shows the impact of papers produced by Lu Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Yue. The network helps show where Lu Yue may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Yue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 129 | |
| 2 | Prognostic value of CRM1 in pancreas cancer. | 2009 | 124 |
| 3 | 2015 | 62 | |
| 4 | 2013 | 54 | |
| 5 | 2017 | 53 | |
| 6 | 2015 | 46 | |
| 7 | 2016 | 34 | |
| 8 | 2000 | 34 | |
| 9 | 2014 | 30 | |
| 10 | 2022 | 30 | |
| 11 | 2014 | 29 | |
| 12 | 2019 | 24 | |
| 13 | 2013 | 23 | |
| 14 | 2012 | 23 | |
| 15 | 2017 | 21 | |
| 16 | 2016 | 17 | |
| 17 | [A preliminary observation of preventive and blocking effect of Gynostemma pentaphyllum (Thunb) Makino on esophageal cancer in rats]. | 1995 | 16 |
| 18 | 2014 | 15 | |
| 19 | 2016 | 14 | |
| 20 | 2015 | 13 |
About Lu Yue
Lu Yue is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 34 papers that have together received 866 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers), Peptidase Inhibition and Analysis (4 papers), Cancer-related Molecular Pathways (3 papers), Cancer-related gene regulation (3 papers), MicroRNA in disease regulation (3 papers) and Advanced Radiotherapy Techniques (3 papers). The work is most often cited by research in Cancer Research (234 citations), Biological Psychiatry (29 citations), Molecular Biology (627 citations), Oncology (227 citations) and Hematology (45 citations). Lu Yue has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Ruyong Yao, Liwei Wang, Weiyi Huang, Yuanjue Sun, Xiaohan Zhou, Wensheng Qiu, Yasai Yao, Fang Zhou, Likun Zhuang and Fei Zhou. Their work appears in journals such as Oncology Reports, Medical Oncology, Clinical and investigative medicine, Molecular Therapy and BMC Medical Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.